AstraZeneca Q3 profit beats estimates as cancer drug sales drive growth (AZN:NYSE)
· seekingalpha.com
AstraZeneca stock jumps after Q3 earnings beat on strong oncology sales.
AstraZeneca (AZN) shares rose 3.5% in premarket trading Friday after the British drugmaker reported stronger-than-expected third-quarter earnings, driven by rob...